Share-based Payment Arrangement, Expense of Definitive Healthcare Corp. from 30 Sep 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Definitive Healthcare Corp. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2020 to 31 Dec 2025.
  • Definitive Healthcare Corp. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $8,161,000, a 11% increase year-over-year.
  • Definitive Healthcare Corp. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $29,144,000, a 23% decline year-over-year.
  • Definitive Healthcare Corp. annual Share-based Payment Arrangement, Expense for 2025 was $29,144,000, a 23% decline from 2024.
  • Definitive Healthcare Corp. annual Share-based Payment Arrangement, Expense for 2024 was $38,085,000, a 22% decline from 2023.
  • Definitive Healthcare Corp. annual Share-based Payment Arrangement, Expense for 2023 was $48,739,000, a 34% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Definitive Healthcare Corp. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $29,144,000 $8,161,000 +$796,000 +11% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $28,348,000 $6,684,000 +$388,000 +6.2% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $27,960,000 $6,980,000 -$1,862,000 -21% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $29,822,000 $7,319,000 -$8,263,000 -53% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $38,085,000 $7,365,000 -$5,889,000 -44% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $43,974,000 $6,296,000 -$5,698,000 -48% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $49,672,000 $8,842,000 -$3,521,000 -28% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $53,193,000 $15,582,000 +$4,454,000 +40% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $48,739,000 $13,254,000 +$1,830,000 +16% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $46,909,000 $11,994,000 +$2,861,000 +31% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $44,048,000 $12,363,000 +$3,358,000 +37% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $40,690,000 $11,128,000 +$4,256,000 +62% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $36,434,000 $11,424,000 +$5,805,000 +103% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $30,629,000 $9,133,000 +$6,816,000 +294% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $23,813,000 $9,005,000 +$7,390,000 +458% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $16,423,000 $6,872,000 +$6,466,000 +1593% 01 Jan 2022 31 Mar 2022 10-Q/A 14 Aug 2023 2023 Q1
Q4 2021 $9,957,000 $5,619,000 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $2,317,000 +$1,859,000 +406% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $1,615,000 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $406,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q3 2020 $458,000 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3

Definitive Healthcare Corp. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $29,144,000 -$8,941,000 -23% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $38,085,000 -$10,654,000 -22% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $48,739,000 +$12,305,000 +34% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $36,434,000 +$26,477,000 +266% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $9,957,000 +$8,210,000 +470% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $1,747,000 01 Jan 2020 31 Dec 2020 10-K/A 14 Aug 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.